Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Neelam V. DeSai, M.D.


This page shows the publications co-authored by Neelam DeSai and Nadine Tung.
Connection Strength

  1. Germline genetic testing in breast cancer: Rationale for the testing of all women diagnosed by the age of 60 years and for risk-based testing of those older than 60 years. Cancer. 2021 03 15; 127(6):828-833.
    View in: PubMed
    Score: 0.927
  2. Medical Management of newly diagnosed breast cancer in a BRCA1/2 mutation carrier. Breast J. 2020 08; 26(8):1506-1512.
    View in: PubMed
    Score: 0.906
  3. Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay. Breast Cancer Res. 2018 07 11; 20(1):75.
    View in: PubMed
    Score: 0.790
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.